Educational information, not medical advice — ask your doctor or midwife.
Track Ma Xing Shi Gan Tang with reminders and record whether it helped, in the app.
Ma Xing Shi Gan Tang is one of the most important classical Chinese herbal formulas, first recorded in the Han Dynasty text Shang Han Lun by Zhang Zhongjing (circa 200 CE). It combines just four ingredients — ephedra, apricot kernel, gypsum, and licorice — in a precise ratio that works together to open the airways, reduce fever, and calm cough. It remains a foundational formula in Traditional Chinese Medicine and is also used in Japanese Kampo medicine under the name Makyokansekito.
The formula works through complementary actions: ephedra opens the airways and promotes breathing by relaxing bronchial smooth muscle; gypsum (a cooling mineral) counterbalances ephedra's warming nature to clear heat and reduce fever; apricot kernel descends lung qi and calms cough; and licorice harmonizes the whole formula while soothing the respiratory tract. Together they address what TCM calls 'lung heat with wheezing' — essentially acute respiratory inflammation with bronchospasm. Modern research suggests the formula reduces airway inflammation, suppresses overactive immune signaling in the lungs, and promotes bronchodilation.
Traditionally prepared as a water decoction by boiling the herbs together. Modern forms include concentrated granule extracts (most convenient), capsules, and tablets. Granule extracts dissolved in hot water most closely replicate the traditional preparation and are preferred by practitioners.
Recorded in the Shang Han Lun (Treatise on Cold Damage), one of the oldest surviving Chinese medicine clinical manuals, written approximately 200 CE. The formula was designed for externally-contracted illness presenting with fever, sweating, thirst, cough, and wheezing — a pattern remarkably aligned with modern presentations of influenza and acute bronchitis. It has been continuously used in China, Japan, Korea, and Taiwan for over 18 centuries and gained renewed research interest during respiratory disease outbreaks including SARS, H1N1 influenza, and COVID-19.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.